Journey Medical Corporation Profile Avatar - Palmy Investing

Journey Medical Corporation

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for …

Drug Manufacturers - Specialty & Generic
US, Scottsdale [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Journey Medical Corporation mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of DERM's Analysis
CIK: 1867066 CUSIP: 48115J109 ISIN: US48115J1097 LEI: - UEI: -
Secondary Listings
DERM has no secondary listings inside our databases.